These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


352 related items for PubMed ID: 16550042

  • 1. Liver transplantation: an update.
    Said A, Lucey MR.
    Curr Opin Gastroenterol; 2006 May; 22(3):272-8. PubMed ID: 16550042
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM, Fernandez M, Da Costa M, Lee KH, Sutedja DS, Tai BC, Tan KC, Isaac J, Prabhakaran K, Lim SG.
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [Abstract] [Full Text] [Related]

  • 5. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL, Kulkarni S, Harper A, Millis JM, Cronin DC.
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MELD-based liver allocation: who is underserved?
    Biggins SW, Bambha K.
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [Abstract] [Full Text] [Related]

  • 9. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.
    Transplantation; 2009 Sep 27; 88(6):826-34. PubMed ID: 19920783
    [Abstract] [Full Text] [Related]

  • 10. Liver transplant considerations for evaluation, CTP, and MELD.
    Mathews SB, Allison W, Lin S.
    Crit Care Nurs Clin North Am; 2010 Sep 27; 22(3):403-11. PubMed ID: 20691390
    [Abstract] [Full Text] [Related]

  • 11. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 27; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
    de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, Pascasio JM, Rodrigo J, Solórzano G, Martín-Vivaldi R, Alonso M.
    Transplantation; 2006 Dec 15; 82(11):1429-35. PubMed ID: 17164713
    [Abstract] [Full Text] [Related]

  • 14. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Dec 15; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 15. Prolonged waiting times for liver transplantation in obese patients.
    Segev DL, Thompson RE, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR.
    Ann Surg; 2008 Nov 15; 248(5):863-70. PubMed ID: 18948816
    [Abstract] [Full Text] [Related]

  • 16. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.
    Arch Surg; 2007 Nov 15; 142(11):1079-85. PubMed ID: 18025337
    [Abstract] [Full Text] [Related]

  • 17. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J, Downey KK, Akoad M, Cacciarelli TV.
    Liver Transpl; 2007 Nov 15; 13(11):1564-9. PubMed ID: 17969210
    [Abstract] [Full Text] [Related]

  • 18. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL.
    Liver Transpl; 2009 Jul 15; 15(7):754-62. PubMed ID: 19562709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K, Feng S.
    Liver Transpl; 2007 Nov 15; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.